Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Nov 24, 2026; 17(11): 125117
Published online Nov 24, 2026. doi: 10.5306/wjco.125117
Published online Nov 24, 2026. doi: 10.5306/wjco.125117
Development and internal validation of a disease-free survival model after radical resection of pathological T4 colorectal adenocarcinoma
Qing-Yuan Zeng, Xue-Lian Wu, Rong-Peng Chen, Guo-Qiang Wang, Department of Gastro intestinal Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guang zhou 510260, Guangdong Province, China
Qian-Ru Hang, Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
Co-first authors: Qing-Yuan Zeng and Xue-Lian Wu.
Co-corresponding authors: Rong-Peng Chen and Guo-Qiang Wang.
Author contributions: Zeng QY and Wu XL contributed equally to this work; Wang GQ and Chen RP designed the study; Chen RP, Zeng QY, and Wu XL collected and analyzed the data; Hang QR contributed to the statistical methodology and prepared the figures and tables; Zeng QY and Wu XL drafted the manuscript; Wang GQ and Chen RP critically revised the manuscript; Wang GQ reviewed the study methodology and findings; all authors interpreted the results, read and approved the final manuscript, and agree to be accountable for all aspects of the work. Wang GQ and Chen RP both contributed substantially to the study design and critical revision of the manuscript and share responsibility for the scientific content. Wang GQ additionally reviewed the study methodology and findings and serves as the contact for editorial correspondence.
AI contribution statement: ChatGPT was used solely for language refinement and improvement of the readability of the manuscript. All AI-generated suggestions were carefully reviewed and verified by the authors.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of The Second Affiliated Hospital of Guangzhou Medical University (Approval No. LYZX-2026-135-01).
Informed consent statement: The requirement for written informed consent was waived by the ethics committee because this retrospective study analyzed existing clinical data and involved no additional intervention.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: De-identified analytic data may be made available by the corresponding author upon reasonable request and subject to institutional approval.
Corresponding author: Guo-Qiang Wang, MD, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guangzhou Medical University, No. 250 Changgang East Road, Haizhu District, Guangzhou 510260, Guangdong Province, China. wgqjyh@126.com
Received: July 1, 2026
Revised: August 19, 2026
Accepted: October 22, 2026
Published online: November 24, 2026
Processing time: 140 Days and 21.5 Hours
Revised: August 19, 2026
Accepted: October 22, 2026
Published online: November 24, 2026
Processing time: 140 Days and 21.5 Hours
Core Tip
Core Tip: This single-center retrospective cohort study developed and internally validated a postoperative disease-free survival model for 440 patients with radically resected pathological T4 colorectal adenocarcinoma. Seven routinely available clinical and pathological variables were retained. The conditional optimism-corrected concordance index was 0.652, and the model showed higher discrimination than a TNM-only comparator within the development cohort. Apparent calibration was generally close, and decision-curve analysis suggested potential net benefit. The complete prediction equation and nomo